• Information Technology
  • Human Resources
  • Careers
  • Giving
  • Library
  • Bookstore
  • Active Living
  • Continuing Education
  • Go Dinos
  • UCalgary Maps
  • UCalgary Directory
  • Academic Calendar
My UCalgary
Webmail
D2L
ARCHIBUS
IRISS
  • Faculty of Arts
  • Cumming School of Medicine
  • Faculty of Environmental Design
  • Faculty of Graduate Studies
  • Haskayne School of Business
  • Faculty of Kinesiology
  • Faculty of Law
  • Faculty of Nursing
  • Faculty of Nursing (Qatar)
  • Schulich School of Engineering
  • Faculty of Science
  • Faculty of Social Work
  • Faculty of Veterinary Medicine
  • Werklund School of Education
  • Information TechnologiesIT
  • Human ResourcesHR
  • Careers
  • Giving
  • Library
  • Bookstore
  • Active Living
  • Continuing Education
  • Go Dinos
  • UCalgary Maps
  • UCalgary Directory
  • Academic Calendar
  • Libraries and Cultural Resources
View Item 
  •   PRISM Home
  • Graduate Studies
  • The Vault: Electronic Theses and Dissertations
  • View Item
  •   PRISM Home
  • Graduate Studies
  • The Vault: Electronic Theses and Dissertations
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Surgical Application of ECM-Biomaterial Enhances Myocardial Recovery Following Myocardial Infarction

Thumbnail
Download
ucalgary_2016_mewhort_holly.pdf (89.00Mb)
Advisor
Fedak, Paul W. M.
Author
Mewhort, Holly E. M.
Committee Member
Giles, Wayne
Duff, Henry
Yong, Voon Wee
Other
Extracellular Matrix
Ischemic Heart Failure
Vasculogenesis
Cardiac Remodeling
Cardiac Surgery
Subject
Medicine and Surgery
Type
Thesis
Metadata
Show full item record

Abstract
Introduction: Ongoing improvements in the management of coronary artery disease continue to reduce mortality following myocardial infarction (MI), however, as a consequence the incidence of ischemic heart failure is on the rise. Healthy extracellular matrix (ECM) provides important cues that regulate cell function and survival. Dysregulation of the ECM following MI leads to cardiac fibrosis, left ventricular (LV) dilatation and heart failure. Here we assess whether ECM biology can be leveraged as a therapy to enhance myocardial recovery following MI. Methods and Results: Epicardial Infarct Repair (EIR), a novel bio-surgical procedure where a healthy ECM-biomaterial (CorMatrix®-ECM®, CorMatrix Cardiovascular Inc., GA, USA) is surgically applied to the epicardial surface of the heart post-MI, was evaluated. In a small animal permanent coronary artery ligation model we demonstrate that animals treated with ECM-biomaterial have improved myocardial function and attenuated LV remodeling compared to shams (ejection fraction (EF): 40.5±7.4% vs. 28.7±13.1%, respectively; p<0.001; LV end diastolic volume (LVEDV): 298.0±63.5μL vs. 373.7±78.8μL, respectively; p<0.0001). In order to determine whether this was the result of recovery of the infarcted myocardium or enhanced compensation by the remote myocardium we employed a large animal preclinical ischemia-reperfusion model and evaluated regional cardiac function by MRI demonstrating functional recovery of the infarcted myocardial territory, specifically infarcted myocardium otherwise defined as non-viable with reperfusion alone (change in regional myocardial contraction at 6-weeks: reperfusion+EIR: 28.6±14.0% vs. reperfusion alone: 4.2±13.5% wall thickening; p<0.05). In order to determine whether these structural and functional improvements are the consequence of passive biomechanical restraint or an active bio-inductive mechanism we compared EIR with active ECM-biomaterial versus inactivated (gluteraldehyde-fixed) ECM-biomaterial using our small animal permanent coronary artery ligation model. Animals treated with active ECM-biomaterial demonstrate improved cardiac function and attenuated structural remodeling when compared to inactivated ECM-biomaterial treated animals (EF: 40.5±7.4% vs. 32.7±9.3 %, respectively; p<0.001; LVEDV: 298.0±63.5μL vs. 341.2±48.4 μL, respectively; p<0.0001) as well as evidence of an active bio-inductive mechanism involving vasculogenesis. Conclusion: EIR with ECM-biomaterial attenuates adverse structural remodeling and improves functional recovery following MI through a bio-inductive mechanism involving vasculogenesis, demonstrating that healthy ECM biology can be leveraged to successfully treat MI.
Corporate
University of Calgary
Faculty
Graduate Studies
Doi
http://dx.doi.org/10.11575/PRISM/27942
Uri
http://hdl.handle.net/11023/3145
Collections
  • The Vault: Electronic Theses and Dissertations

Browse

All of PRISMCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

Statistics

Most Popular ItemsStatistics by CountryMost Popular Authors

  • Email
  • SMS
  • 403.220.8895
  • Live Chat

Energize: The Campaign for Eyes High

Privacy Policy
Website feedback

University of Calgary
2500 University Drive NW
Calgary, AB T2N 1N4
CANADA

Copyright © 2017